Literature DB >> 16644919

Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells.

Emmanuel N Olivier1, Anne C Rybicki, Eric E Bouhassira.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent progenitors that can be found in many connective tissues, including fat, bone, cartilage, and muscle. We report here a method to reproducibly differentiate human embryonic stem cells (hESCs) into MSCs that does not require the use of any feeder layer. The cells obtained with this procedure are morphologically similar to bone marrow MSCs, are contact-inhibited, can be grown in culture for about 20 to 25 passages, have an immunophenotype similar to bone marrow MSCs (negative for CD34 and CD45 and positive for CD13, CD44, CD71, CD73, CD105, CD166, human leukocyte antigen [HLA]-ABC, and stage-specific embryonic antigen [SSEA]-4), can differentiate into osteocytes and adipocytes, and can be used as feeder cells to support the growth of undifferentiated hESCs. The ability to produce MSCs from hESCs should prove useful to produce large amounts of genetically identical and genetically modifiable MSCs that can be used to study the biology of MSCs and for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644919     DOI: 10.1634/stemcells.2005-0648

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  78 in total

1.  Human embryonic stem cell-derived mesenchymal stromal cells.

Authors:  Peiman Hematti
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

Review 2.  Stem Cells in Skeletal Tissue Engineering: Technologies and Models.

Authors:  Mark T Langhans; Shuting Yu; Rocky S Tuan
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

Review 3.  Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine.

Authors:  Wei Seong Toh; Eng Hin Lee; Tong Cao
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 4.  Controlled differentiation of stem cells.

Authors:  Nathaniel S Hwang; Shyni Varghese; Jennifer Elisseeff
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

5.  In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.

Authors:  Nathaniel S Hwang; Shyni Varghese; H Janice Lee; Zijun Zhang; Zhaohui Ye; Jongwoo Bae; Linzhao Cheng; Jennifer Elisseeff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

6.  Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.

Authors:  Erin A Kimbrel; Nicholas A Kouris; Gregory J Yavanian; Jianlin Chu; Yu Qin; Ann Chan; Ram P Singh; Deborah McCurdy; Lynn Gordon; Ralph D Levinson; Robert Lanza
Journal:  Stem Cells Dev       Date:  2014-05-02       Impact factor: 3.272

7.  Differentiation in stem/progenitor cells along fetal or adult hepatic stages requires transcriptional regulators independently of oscillations in microRNA expression.

Authors:  Sriram Bandi; Sanchit Gupta; Tatyana Tchaikovskaya; Sanjeev Gupta
Journal:  Exp Cell Res       Date:  2018-06-06       Impact factor: 3.905

8.  Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells.

Authors:  Yi-Ping Liu; Peiman Hematti
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

9.  Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement-chitosan-RGD scaffold for bone repair.

Authors:  Wenchuan Chen; Hongzhi Zhou; Michael D Weir; Minghui Tang; Chongyun Bao; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2013-01-28       Impact factor: 3.845

10.  Bone scaffold architecture modulates the development of mineralized bone matrix by human embryonic stem cells.

Authors:  Ivan Marcos-Campos; Darja Marolt; Petros Petridis; Sarindr Bhumiratana; Daniel Schmidt; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2012-08-16       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.